William K. Evans
Cancer Care Ontario
620 University Avenue
Toronto
Ontario
Name/email consistency: high
- Gefitinib does not improve survival when combined with gemcitabine and cisplatin in people with advanced non-small-cell lung cancer. Evans, W.K. Cancer Treat. Rev. (2004)
- Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer. Evans, W.K. Cancer Treat. Rev. (2004)
- Adjuvant chemotherapy with uracil-tegafur prolongs overall survival in people with primary adenocarcinoma of the lung. Evans, W.K. Cancer Treat. Rev. (2004)
- Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis. Evans, W.K., Coyle, D., Gafni, A., Walker, H. Chronic. Dis. Can (2003)
- Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs. Evans, W.K., Nefsky, M., Pater, J., Browman, G., Cowan, D.H. Chronic. Dis. Can (2002)









